tiprankstipranks
Edwards Lifesciences (MX:EW)
:EW
Mexico Market
EW
Edwards Lifesciences
RESEARCH TOOLSreports

Edwards Lifesciences (EW) Ratios

1 Followers

Edwards Lifesciences Ratios

MX:EW's free cash flow for Q2 2026 was $0.78. For the 2026 fiscal year, MX:EW's free cash flow was decreased by $ and operating cash flow was $0.30. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 4.52 3.72 4.18 3.38 3.03
Quick Ratio
 3.77 3.09 3.45 2.62 2.17
Cash Ratio
 1.93 1.62 2.02 0.95 0.75
Solvency Ratio
 0.36 0.37 1.45 0.59 0.68
Operating Cash Flow Ratio
 1.14 0.88 0.36 0.75 1.19
Short-Term Operating Cash Flow Coverage
 0.00 65.11 0.00 0.00 0.00
Net Current Asset Value
$ 3.68B$ 3.38B$ 3.29B$ 1.39B$ 610.00M
Leverage Ratios
Debt-to-Assets Ratio
 0.05 0.05 0.05 0.07 0.08
Debt-to-Equity Ratio
 0.07 0.07 0.07 0.10 0.12
Debt-to-Capital Ratio
 0.06 0.06 0.07 0.09 0.11
Long-Term Debt-to-Capital Ratio
 0.05 0.05 0.06 0.08 0.09
Financial Leverage Ratio
 1.31 1.32 1.31 1.41 1.43
Debt Service Coverage Ratio
 0.00 49.49 79.34 78.55 65.45
Interest Coverage Ratio
 0.00 0.00 69.63 81.10 64.98
Debt to Market Cap
 0.01 0.01 0.01 0.01 0.01
Interest Debt Per Share
 1.22 1.21 1.20 1.16 1.16
Net Debt to EBITDA
 -1.43 -1.56 -1.36 -0.29 -0.04
Profitability Margins
Gross Profit Margin
77.98%78.13%79.46%79.30%78.31%
EBIT Margin
21.76%20.98%28.82%27.74%33.32%
EBITDA Margin
23.65%23.56%31.68%30.64%36.42%
Operating Profit Margin
28.09%26.97%25.35%28.49%31.63%
Pretax Profit Margin
21.77%20.98%28.46%27.39%32.84%
Net Profit Margin
15.43%17.69%76.75%27.99%28.28%
Continuous Operations Profit Margin
15.03%17.40%25.66%24.35%28.28%
Net Income Per EBT
70.89%84.33%269.66%102.19%86.11%
EBT Per EBIT
77.48%77.80%112.29%96.15%103.82%
Return on Assets (ROA)
7.25%7.84%31.98%14.98%18.35%
Return on Equity (ROE)
9.69%10.38%41.75%21.09%26.21%
Return on Capital Employed (ROCE)
14.80%13.77%11.94%17.47%23.42%
Return on Invested Capital (ROIC)
10.20%11.40%10.74%15.49%20.09%
Return on Tangible Assets
9.54%9.94%41.32%17.94%22.24%
Earnings Yield
1.93%2.15%9.43%3.03%3.30%
Efficiency Ratios
Receivables Turnover
 6.81 6.65 7.48 6.05 7.70
Payables Turnover
 6.82 5.83 5.66 5.56 5.78
Inventory Turnover
 1.27 1.18 1.03 1.15 1.33
Fixed Asset Turnover
 3.35 3.17 3.05 2.99 3.12
Asset Turnover
 0.47 0.44 0.42 0.54 0.65
Working Capital Turnover Ratio
 1.29 1.25 1.43 2.04 2.55
Cash Conversion Cycle
 287.64 302.08 339.27 312.59 258.05
Days of Sales Outstanding
 53.56 54.87 48.81 60.33 47.41
Days of Inventory Outstanding
 287.59 309.79 354.94 317.92 273.78
Days of Payables Outstanding
 53.52 62.58 64.48 65.66 63.14
Operating Cycle
 341.15 364.66 403.75 378.25 321.19
Cash Flow Ratios
Operating Cash Flow Per Share
 2.98 2.73 0.91 1.48 1.97
Free Cash Flow Per Share
 2.49 2.28 0.49 1.04 1.54
CapEx Per Share
 0.50 0.44 0.42 0.44 0.43
Free Cash Flow to Operating Cash Flow
 0.83 0.84 0.53 0.70 0.78
Dividend Paid and CapEx Coverage Ratio
 6.00 6.13 2.15 3.36 4.60
Capital Expenditure Coverage Ratio
 6.00 6.13 2.15 3.36 4.60
Operating Cash Flow Coverage Ratio
 2.44 2.26 0.77 1.31 1.76
Operating Cash Flow to Sales Ratio
 0.26 0.26 0.10 0.18 0.23
Free Cash Flow Yield
2.76%2.68%0.66%1.36%2.06%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 51.84 46.33 10.61 32.99 30.35
Price-to-Sales (P/S) Ratio
 7.98 8.22 8.13 9.23 8.58
Price-to-Book (P/B) Ratio
 4.90 4.82 4.43 6.96 7.95
Price-to-Free Cash Flow (P/FCF) Ratio
 36.23 37.34 152.63 73.49 48.44
Price-to-Operating Cash Flow Ratio
 30.23 31.25 81.59 51.64 37.91
Price-to-Earnings Growth (PEG) Ratio
 -0.69 -0.63 0.05 -5.41 14.63
Price-to-Fair Value
 4.90 4.82 4.43 6.96 7.95
Enterprise Value Multiple
 32.30 33.31 24.32 29.85 23.52
Enterprise Value
 49.74B 47.62B 41.90B 45.81B 46.11B
EV to EBITDA
 32.30 33.31 24.32 29.85 23.52
EV to Sales
 7.64 7.85 7.70 9.14 8.57
EV to Free Cash Flow
 34.70 35.67 144.54 72.78 48.36
EV to Operating Cash Flow
 28.91 29.85 77.27 51.14 37.85
Tangible Book Value Per Share
 12.82 12.72 11.89 8.53 7.04
Shareholders’ Equity Per Share
 18.42 17.68 16.73 10.96 9.38
Tax and Other Ratios
Effective Tax Rate
 0.31 0.17 0.10 0.11 0.14
Revenue Per Share
 11.30 10.38 9.10 8.26 8.70
Net Income Per Share
 1.74 1.84 6.98 2.31 2.46
Tax Burden
 0.71 0.84 2.70 1.02 0.86
Interest Burden
 1.00 1.00 0.99 0.99 0.99
Research & Development to Revenue
 0.17 0.18 0.19 0.19 0.18
SG&A to Revenue
 0.34 0.34 0.33 0.00 0.00
Stock-Based Compensation to Revenue
 0.03 0.03 0.03 0.03 0.02
Income Quality
 1.71 1.49 0.13 0.64 0.80
Currency in USD